Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Androgen Receptor Targeting with Enzalutamide for Mantle Cell Lymphoma: Safety and Efficacy

Victor A. Chow, MD, Paul S. Martin, MD, Stephen D. Smith, MD, Brian G. Till, MD, Solomon A. Graf, MD, Kerstin L. Edlefsen, MD, Lindsay M. Hannan, MD MSPH, Elahe A. Mostaghel, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 5254.

https://doi.org/10.1182/blood-2019-125462

Published: 2019

Journal Articles

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

Sang Eun Yoon, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD, Young Hyeh Ko, MD, Kim Yeon Jeong, PhD, Park Donghyun, PhD

Blood (2019) 134 (Supplement_1): 1491.

https://doi.org/10.1182/blood-2019-130075

Published: 2019

Journal Articles

Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms

Jiwon Kim, MD, Spencer Krichevsky, BS, Neil K Mehta, MD, Sara Rodriguez-Diego, MD, Meridith P Pollie, BS, Richard T Silver, MD, Andrew I Schafer, MD, Ellen K Ritchie, MD, Mia Wiese, BS, Claudia Sosner, BA, Evelyn M Horn, MD, Richard B Devereux, MD, Jonathan W Weinsaft, MD, Joseph Scandura, MDPhD

Blood (2017) 130 (Supplement 1): 324.

https://doi.org/10.1182/blood.V130.Suppl_1.324.324

Published: 2017

Journal Articles

A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Matthew S. Davids, MD, Haesook T Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Caron Jacobson, MD, Samuel Y. Ng, MDPhD, Ann S LaCasce, MD MSc, Ephraim P. Hochberg, MD, Ronald W. Takvorian, MD, Jeremy S. Abramson, MD MMSc, David C. Fisher, MD PhD, Jennifer R. Brown, MD PhD

Blood (2017) 130 (Supplement 1): 496.

https://doi.org/10.1182/blood.V130.Suppl_1.496.496

Published: 2017

Journal Articles

Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Matthew S. Davids, Haesook T. Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Caron A. Jacobson, MD, Ephraim Hochberg, MD, Ronald Takvorian, MD, Jeremy S. Abramson, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD

Blood (2016) 128 (22): 3243.

https://doi.org/10.1182/blood.V128.22.3243.3243

Published: 2016

Journal Articles

TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study

Matthew S. Davids, Haesook T. Kim, PhD, Alyssa Nicotra, BA, Alexandra Savell, BS, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Hari P. Miskin, MS, Peter Sportelli, Asad Bashey, MD PhD, Laura Stampleman, MD, Jens Rueter, MD, Adam Boruchov, MD, Jon Arnason, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Jennifer R. Brown

Blood (2016) 128 (22): 641.

https://doi.org/10.1182/blood.V128.22.641.641

Published: 2016

Journal Articles

Evaluation of Cell Types and Morphologies in Sickle Cell Disease with an Imaging Flow Cytometer

Hasan Tahsin Ozpolat, MD, Tim Chang, PhD, Junmei Chen, PhD, Xiaoping Wu, PhD, Colette Norby, MS, Barbara A Konkle, MD, Jose A. Lopez, MD

Blood (2015) 126 (23): 972.

https://doi.org/10.1182/blood.V126.23.972.972

Published: 2015

Journal Articles

Preliminary Results of a Phase Ib Study of Duvelisib in Combination with FCR (dFCR) in Previously Untreated, Younger Patients with CLL

Matthew S. Davids, MD, Haesook T. Kim, PhD, Elizabeth Gilbert, Leslie Cowen, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Jon E. Arnason, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD

Blood (2015) 126 (23): 4158.

https://doi.org/10.1182/blood.V126.23.4158.4158

Published: 2015

Journal Articles

New Structural Insights into High Affinity Membrane Binding By Coagulation Factor V/Va

Shekhar Kumar, PhD, Steven Stayrook, PhD, James A. Huntington, PhD, Rodney M. Camire, PhD, Sriram Krishnaswamy, PhD

Blood (2014) 124 (21): 4216.

https://doi.org/10.1182/blood.V124.21.4216.4216

Published: 2014

Journal Articles

Integration Of CT-Based Measurements Into PET Assessment Significantly Improves The Positive Predictive Value Of Surveillance FDG PET/CT In Patients With Diffuse Large B Cell Lymphoma

Noa Lavi, MD, Gali Shapira, MD, Ariel Zilberlicht, MD, Noam Benyamini, MD, Dan Farbstein, MD, Eldad J Dann, MD, Rachel Bar-Shalom, MD, Irit Avivi, MD

Blood (2013) 122 (21): 4296.

https://doi.org/10.1182/blood.V122.21.4296.4296

Published: 2013

Journal Articles

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

Jennifer R Brown, MD, PhD, Susan O'Brien, MD, C Daniel Kingsley, MD, FACP, Herbert Eradat, MS, MD, John M. Pagel, MD, PhD, James Lymp, PhD, Jamie Hirata, PharmD, Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 523.

https://doi.org/10.1182/blood.V122.21.523.523

Published: 2013

Journal Articles

Pulmonary Hypertension May Be a Relevant Comorbidity in Patients with Myelodysplastic Syndromes

Xhylsime Kqiku, MD, Gabor Kovacs, MD, Sonja Reitter, MD, Heinz Sill, MD, Horst Olschewski, MD

Blood (2011) 118 (21): 5039.

https://doi.org/10.1182/blood.V118.21.5039.5039

Published: 2011

Journal Articles

A Comparison of Echocardiogram Screening for Pulmonary Hypertension in Asymptomatic and Symptomatic Patients with Sickle Cell Disease

Rowena R Thomas-Dewing, MBBS., MRCP, John Chambers, MA., MD., FRCP., FACP, Nicholas Hart, MRCP, PhD, Jo Howard, MB BChir, MRCP, FRCPath

Blood (2008) 112 (11): 4801.

https://doi.org/10.1182/blood.V112.11.4801.4801

Published: 2008

Journal Articles

Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation

Gefei Zeng, Sarah M. Taylor, Janet R. McColm, Nicholas C. Kappas, Joseph B. Kearney, Lucy H. Williams, Mary E. Hartnett, Victoria L. Bautch

Blood (2006) 109 (4): 1345–1352.

https://doi.org/10.1182/blood-2006-07-037952

Published: 2006

Includes: Multimedia, Supplemental data

NARROW

Androgen Receptor Targeting with Enzalutamide for Mantle Cell Lymphoma: Safety and Efficacy

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms

A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study

Evaluation of Cell Types and Morphologies in Sickle Cell Disease with an Imaging Flow Cytometer

Preliminary Results of a Phase Ib Study of Duvelisib in Combination with FCR (dFCR) in Previously Untreated, Younger Patients with CLL

New Structural Insights into High Affinity Membrane Binding By Coagulation Factor V/Va

Integration Of CT-Based Measurements Into PET Assessment Significantly Improves The Positive Predictive Value Of Surveillance FDG PET/CT In Patients With Diffuse Large B Cell Lymphoma

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

Pulmonary Hypertension May Be a Relevant Comorbidity in Patients with Myelodysplastic Syndromes

A Comparison of Echocardiogram Screening for Pulmonary Hypertension in Asymptomatic and Symptomatic Patients with Sickle Cell Disease

Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only